Novo Resources has bolstered its bank balance with the sale of its remaining 20 per cent interest in the Quartz Hill ...

Catalent is vulnerable to facility closures whether from natural disasters or manufacturing issues, and a warning letter from the FDA or other regulatory agency can result in manufacturing delays or ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

Eli Lilly's Zepbound and Novo Nordisk's Wegovy, both priced at over $1,000 a month, have faced resistance from employers due to their high up-front costs. However, drugmakers argue that covering these ...

Prior to the election, Biden was eager to talk about the existential threat that the president-elect posed to American democracy and the nightmarish future he said would follow if Trump ever returned ...

Kennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

With nearly $14 billion sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, ...

Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has ...

Austroid Australia Pty Ltd (a related entity of Liatam Mining Pty Ltd) has acquired the remaining 20% of the Quartz Hill ...

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will ...

Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a ...